123 related articles for article (PubMed ID: 38855588)
41. Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study.
Chen WK; Wu ZG; Xiao YB; Wang QQ; Yu DD; Cai J; Zhou CF
Technol Cancer Res Treat; 2021; 20():15330338211004914. PubMed ID: 33929915
[TBL] [Abstract][Full Text] [Related]
42. Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma.
Wang K; Ma W; Wang J; Yu L; Zhang X; Wang Z; Tan B; Wang N; Bai B; Yang S; Liu H; Zhu S; Cheng Y
J Thorac Oncol; 2012 Sep; 7(9):1457-61. PubMed ID: 22843085
[TBL] [Abstract][Full Text] [Related]
43. Impact of diabetes mellitus on the prognostic value of the neutrophil-lymphocyte ratio in renal cell carcinoma.
Zheng Y; Bao LM; Ye J; Pan Y; Wang Q; Gao X
Exp Ther Med; 2019 Feb; 17(2):1268-1275. PubMed ID: 30680002
[TBL] [Abstract][Full Text] [Related]
44. [Tumor-stroma ratio is an independent prognostic factor of non-small cell lung cancer].
Wang Z; Liu H; Zhao R; Zhang H; Liu C; Song Y
Zhongguo Fei Ai Za Zhi; 2013 Apr; 16(4):191-6. PubMed ID: 23601299
[TBL] [Abstract][Full Text] [Related]
45. 53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: a study based on TCGA and SEER database.
Tang F; Lu Z; He C; Zhang H; Wu W; He Z
BMC Cancer; 2021 May; 21(1):638. PubMed ID: 34051738
[TBL] [Abstract][Full Text] [Related]
46. The prognostic value of tumor-stromal ratio combined with TNM staging system in esophagus squamous cell carcinoma.
He R; Li D; Liu B; Rao J; Meng H; Lin W; Fan T; Hao B; Zhang L; Lu Z; Feng H; Zhang Z; Yuan J; Geng Q
J Cancer; 2021; 12(4):1105-1114. PubMed ID: 33442408
[No Abstract] [Full Text] [Related]
47. Multiperspective quantitative tumor-stroma ratio reveals histological areas associated with poor outcomes in oral squamous cell carcinoma.
Wang S; Si Q; Wu Y; Sun Y; Zhang W; Huang X; Zeng T; Chen S; Yang X; Ni Y; Hu Q
Cancer Med; 2023 Jun; 12(11):12161-12172. PubMed ID: 37184217
[TBL] [Abstract][Full Text] [Related]
48. High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients.
Pichler M; Hutterer GC; Stojakovic T; Mannweiler S; Pummer K; Zigeuner R
Br J Cancer; 2013 Sep; 109(5):1123-9. PubMed ID: 23922109
[TBL] [Abstract][Full Text] [Related]
49. Impact of Tumor-Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review.
Gao J; Shen Z; Deng Z; Mei L
Front Oncol; 2021; 11():738080. PubMed ID: 34868930
[TBL] [Abstract][Full Text] [Related]
50. Prognostic prediction value of the clinical-radiomics tumour-stroma ratio in locally advanced rectal cancer.
Cai C; Hu T; Rong Z; Gong J; Tong T
Eur J Radiol; 2024 Jan; 170():111254. PubMed ID: 38091662
[TBL] [Abstract][Full Text] [Related]
51. Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma.
Liu J; Liu J; Li J; Chen Y; Guan X; Wu X; Hao C; Sun Y; Wang Y; Wang X
Gynecol Oncol; 2014 Jan; 132(1):81-6. PubMed ID: 24219981
[TBL] [Abstract][Full Text] [Related]
52. Tumour Budding and Tumour Stroma Ratio are Reliable Predictors for Death and Recurrence in Elderly Stage I Colon Cancer Patients.
Zengin M
Pathol Res Pract; 2019 Nov; 215(11):152635. PubMed ID: 31564570
[TBL] [Abstract][Full Text] [Related]
53. Tumor-Stroma Ratio is an independent predictor for overall survival and disease free survival in gastric cancer patients.
Aurello P; Berardi G; Giulitti D; Palumbo A; Tierno SM; Nigri G; D'Angelo F; Pilozzi E; Ramacciato G
Surgeon; 2017 Dec; 15(6):329-335. PubMed ID: 28629870
[TBL] [Abstract][Full Text] [Related]
54. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
55. Computerized Assessment of the Tumor-stromal Ratio and Proposal of a Novel Nomogram for Predicting Survival in Invasive Breast Cancer.
Qian X; Xiao F; Chen YY; Yuan JP; Liu XH; Wang LW; Xiong B
J Cancer; 2021; 12(12):3427-3438. PubMed ID: 33995621
[No Abstract] [Full Text] [Related]
56. Prognostic value of desmoplastic stromal reaction, tumor budding and tumor-stroma ratio in stage II colorectal cancer.
Fan S; Cui X; Zheng L; Ma W; Zheng S; Wang J; Qi L; Ye Z
J Gastrointest Oncol; 2022 Dec; 13(6):2903-2921. PubMed ID: 36636094
[TBL] [Abstract][Full Text] [Related]
57. Overall and cause-specific survival for mucoepidermoid carcinoma of the major salivary glands: Analysis of 2210 patients.
Taylor ZC; Kaya EA; Bunn JD; Guss ZD; Mitchell BJ; Fairbanks RK; Lamoreaux WT; Wagner AE; Peressini BJ; Lee CM
World J Clin Oncol; 2020 Dec; 11(12):1029-1044. PubMed ID: 33437665
[TBL] [Abstract][Full Text] [Related]
58. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
59. The tumor-stroma ratio is an independent predictor for survival in nasopharyngeal cancer.
Zhang XL; Jiang C; Zhang ZX; Liu F; Zhang F; Cheng YF
Oncol Res Treat; 2014; 37(9):480-4. PubMed ID: 25231688
[TBL] [Abstract][Full Text] [Related]
60. Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
Pyo JS; Kim NY; Min KW; Kang DW
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512068
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
